ORLANCE, INC

MACH-1™: Pow(d)ering your skin to deliver disease protection and treatment.

Seattle, United States · Founded 2018 · $3.0M raised

Employees
1–10
Founded
2018
Business Model
B2G
Total Funding
$3.0M
Last Round
$3.0M GrantJan 2024
Rounds
2

About

Orlance is a biotech company developing the MACH-1™ needle-free, powdered vaccine and immunotherapy delivery platform. Backed by $16.8M in NIH SBIR funding, MACH-1 delivers nucleic acid vaccines directly into the epidermis, eliminating cold chain requirements and reducing doses by up to 90%. Lead programs target influenza, cancer, and hepatitis B.

Summary

ORLANCE, INC is a Biotech company based in Seattle, United States, founded in 2018. It has raised $3.0M in total across 2 rounds, most recently a $3.0M Grant round in Jan 2024. Investors include National Institutes of Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2024
$3.0M

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ORLANCE, INC on Indexed.vc
<a href="https://indexed.vc/companies/orlance-inc"><img src="https://indexed.vc/api/badge/company/orlance-inc" alt="ORLANCE, INC on Indexed.vc" width="260" height="76" /></a>